This site is intended for healthcare professionals
Light microscopy of the internal lining of the urinary bladder; haematoxylin and eosin stain
Learning Zone

Managing High-Risk NMIBC

Last updated:27th Jan 2025
Published:20th Jan 2025

The treatment landscape for high-risk non-muscle-invasive bladder cancer (NMIBC) is rapidly evolving. From the latest trial data to real-world insights, this resource aims to equip you with the information you need to select the right treatment options for your patients.

Check in here over the next 12 months to:

  • Review key points from the guidelines and practical advice from experts on the assessment of suspected bladder cancer
  • Find the latest data on current and emerging immunotherapies for high-risk NMIBC, including updates from ASCO GU, EAU, and ASCO
  • Listen to our expert podcast series for guidance on presentation and diagnosis of NMIBC, plus selecting the best care pathway for individual patients
  • Hear healthcare professionals and patient advocates discuss how to optimize support for people with NMIBC

Advances in diagnosis and management

Read about NMIBC risk stratification, the latest diagnostic technologies, and the recommended diagnostic algorithm for patients with NMIBC

Learn more

Welcome: